Glucocorticoid-Induced Osteoporosis

American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1996;39:1791-801.10.1002/art.1780391104Search in Google Scholar

Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A. Glucocortcoid-induced osteoporosis: an update. Trends Endocrnol Metab 2006;17:144-9.10.1016/j.tem.2006.03.009Search in Google Scholar

Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990:112:352-64.10.7326/0003-4819-112-5-352Search in Google Scholar

Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 2005;34:341-56.10.1016/j.ecl.2005.01.014Search in Google Scholar

Reid IR, Grey AB. Corticosteroid osteoporosis. Bailliere Clin Rheumatol 1993;7:573-87.10.1016/S0950-3579(05)80080-9Search in Google Scholar

Adachi J, Ionnidis G. Primer on corticosteroid-induced osteoporosis. Philadelphia (PA): Lippincott Williams & Wilkins; 2000.Search in Google Scholar

Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 2001;16:97-103.10.1359/jbmr.2001.16.1.97Search in Google Scholar

Suda T, Takahashi N, Udagawa N, Jimi E, gillepsie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-57.10.1210/edrv.20.3.0367Search in Google Scholar

Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;81:3441-7.Search in Google Scholar

Canalis E. Mechanisms of glucocorticoid-induced osteoporosis. Curr Opin Rheumatol 2003;15:454-7.10.1097/00002281-200307000-00013Search in Google Scholar

Van Staa TP. The patogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 2006;79:129-37.10.1007/s00223-006-0019-1Search in Google Scholar

Haugeberg G, Uhlig T, Falch JA, Halse JI, Lems WF, Dijkmans BA, Woolf AD. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid arthritis register. Arthritis Rheum 2000;43:422-530.10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-YSearch in Google Scholar

Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 1993;306:558.10.1136/bmj.306.6877.558Search in Google Scholar

Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis 2001;60:521-2.10.1136/ard.60.5.521Search in Google Scholar

Van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. Q J Med 2000;93:105-11.10.1093/qjmed/93.2.105Search in Google Scholar

Filipčić A, Fotez I, Varnai VM, Babić-Naglić Đ, Ćurković B. Primjena lijekova u bolesnika s reumatoidnim artritisom u realnom životu. Reumatizam 2004;51:68.Search in Google Scholar

Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG. Public health imapct of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol 2001;51:601-7.10.1046/j.0306-5251.2001.bjcp.1385.xSearch in Google Scholar

Van Staa TP, Laan RF, Barton I, Cohen S, Reid DM, Cooper C. Predictors and bone density treshold for vertebral fracture in patients using oral glucocorticosteroids. Arthritis Rheum 2003;48:3224-9.10.1002/art.11283Search in Google Scholar

Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Eisman JA, Mc Closkey EV, Mellstrom D, Melton LJ 3rd, Pols HA, Reeve J, Silman AJ, Tenenhouse A. A meta-anlysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19:893-9.10.1359/JBMR.040134Search in Google Scholar

Van Staa TP, Leufkens HGM, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis Int 2002;13:777-87.10.1007/s001980200108Search in Google Scholar

American College of Rheumatology Ad Hoc Committee on Glucocorticoid-induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001;44:1496-503.10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5Search in Google Scholar

Haugeberg G, Orstavik RE, Kvien TK. Effects of rheumatoid arthritis on bone. Curr Opin Rheumatol 2003;15:469-75.10.1097/00002281-200307000-00016Search in Google Scholar

Sambrook PN. How to prevent steroid induced osteoporosis. Ann Rheum Dis 2005;64:176-8.10.1136/ard.2003.018556Search in Google Scholar

Laktašić-Žerjavić N, Ćurković B, Crnčić N, Babić-Naglić Đ. Osteoporosis in rheumatoid arthritis: a comparison between corticosteroid treated and non treated patients. Joint Bone Spine 2006;73:225-6.Search in Google Scholar

Royal College of Physicians, National osteoporosis Society, Bone and Tooth Society of Great Britain. Glucocorticoid-induced osteoporosis - guidelines for prevention and treatment. London: Royal College of Physicians; 2002.Search in Google Scholar

Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG. Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis. N Engl J Med 1998;339:292-9.10.1056/NEJM199807303390502Search in Google Scholar

Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlvwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids. Arthritis Rheum 2001;44:202-11.10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-WSearch in Google Scholar

Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, Doherty SM, Maricic M, Rosen C, Brown J, Barton I, Chines AA. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Inter 2000;87:277-85.10.1007/s002230001146Search in Google Scholar

Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. J Clin Invest 1998;102:1627-33.10.1172/JCI3914Search in Google Scholar

Mužić V, Babić-Naglić Đ, Potočki K, Ćurković B. Osteoporotic vertebral fractures in inflammatory rheumatic patients. Zdravniški vestnik 2006;7(suppl. I):40-1.Search in Google Scholar

Zochling J, Nash P, Riordan J, Sambrook N. Use of corticosteroids and bone-active medications in clinical practice. APLAR J Rheumatol 2006;9:37-42.10.1111/j.1479-8077.2006.00162.xSearch in Google Scholar